These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 18203329

  • 1. Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks.
    Lisbona MP, Maymo J, Perich J, Almirall M, Pérez-García C, Carbonell J.
    J Rheumatol; 2008 Mar; 35(3):394-7. PubMed ID: 18203329
    [Abstract] [Full Text] [Related]

  • 2. Rapid reduction in tenosynovitis of the wrist and fingers evaluated by MRI in patients with rheumatoid arthritis after treatment with etanercept.
    Lisbona MP, Maymó J, Perich J, Almirall M, Carbonell J.
    Ann Rheum Dis; 2010 Jun; 69(6):1117-22. PubMed ID: 20448287
    [Abstract] [Full Text] [Related]

  • 3. Lessons from magnetic resonance imaging studies in rheumatoid arthritis.
    Quinn M.
    J Rheumatol; 2008 Mar; 35(3):372-4. PubMed ID: 18322971
    [No Abstract] [Full Text] [Related]

  • 4. Clinical outcome and imaging changes after intraarticular (IA) application of etanercept or methylprednisolone in rheumatoid arthritis: magnetic resonance imaging and ultrasound-Doppler show no effect of IA injections in the wrist after 4 weeks.
    Boesen M, Boesen L, Jensen KE, Cimmino MA, Torp-Pedersen S, Terslev L, Koenig M, Danneskiold-Samsøe B, Røgind H, Bliddal H.
    J Rheumatol; 2008 Apr; 35(4):584-91. PubMed ID: 18322991
    [Abstract] [Full Text] [Related]

  • 5. May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot study.
    Migliore A, Massafra U, Bizzi E, Argento G, Diamanti AP, Germano V, Tormenta S, Arduini F, Iannessi F, Granatas M, Laganà B.
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):363-9. PubMed ID: 22530354
    [Abstract] [Full Text] [Related]

  • 6. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P, Malghem J, Nzeusseu Toukap A, Depresseux G, Lauwerys BR, Westhovens R, Luyten FP, Corluy L, Houssiau FA, Verschueren P.
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [Abstract] [Full Text] [Related]

  • 7. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
    Catrina AI, Trollmo C, af Klint E, Engstrom M, Lampa J, Hermansson Y, Klareskog L, Ulfgren AK.
    Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
    [Abstract] [Full Text] [Related]

  • 8. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis.
    Gerlag DM, Haringman JJ, Smeets TJ, Zwinderman AH, Kraan MC, Laud PJ, Morgan S, Nash AF, Tak PP.
    Arthritis Rheum; 2004 Dec; 50(12):3783-91. PubMed ID: 15593225
    [Abstract] [Full Text] [Related]

  • 9. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
    van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Rustenburg F, Baggen JM, Verweij CL, Tak PP.
    Ann Rheum Dis; 2008 Apr; 67(4):563-6. PubMed ID: 18042642
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M, Levarht EW, Sont JK, Huizinga TW, Toes RE, van Laar JM.
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [Abstract] [Full Text] [Related]

  • 11. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I.
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [Abstract] [Full Text] [Related]

  • 12. Effect of very early treatment in rheumatoid arthritis on bone oedema and synovitis, using magnetic resonance imaging.
    Kosta PE, Voulgari PV, Zikou AK, Tsampoulas K, Drosos AA, Argyropoulou MI.
    Scand J Rheumatol; 2012 Oct; 41(5):339-44. PubMed ID: 22646866
    [Abstract] [Full Text] [Related]

  • 13. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.
    Kruithof E, De Rycke L, Roth J, Mielants H, Van den Bosch F, De Keyser F, Veys EM, Baeten D.
    Arthritis Rheum; 2005 Dec; 52(12):3898-909. PubMed ID: 16329106
    [Abstract] [Full Text] [Related]

  • 14. Histological analysis of synovium by treatment of etanercept for rheumatoid arthritis.
    Suzuki Y, Inoue K, Chiba J, Inoue Y, Kanbe K.
    Int J Rheum Dis; 2009 Apr; 12(1):7-13. PubMed ID: 20374310
    [Abstract] [Full Text] [Related]

  • 15. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab.
    Zikou AK, Argyropoulou MI, Voulgari PV, Xydis VG, Nikas SN, Efremidis SC, Drosos AA.
    J Rheumatol; 2006 Feb; 33(2):219-23. PubMed ID: 16465650
    [Abstract] [Full Text] [Related]

  • 16. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.
    Baraliakos X, Davis J, Tsuji W, Braun J.
    Arthritis Rheum; 2005 Apr; 52(4):1216-23. PubMed ID: 15818694
    [Abstract] [Full Text] [Related]

  • 17. Regional variation and differential response to therapy for knee synovitis adjacent to the cartilage-pannus junction and suprapatellar pouch in inflammatory arthritis: implications for pathogenesis and treatment.
    Rhodes LA, Tan AL, Tanner SF, Radjenovic A, Hensor EM, Reece R, O'Connor P, Emery P, McGonagle D.
    Arthritis Rheum; 2004 Aug; 50(8):2428-32. PubMed ID: 15334454
    [Abstract] [Full Text] [Related]

  • 18. Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis.
    Guis S, Balandraud N, Bouvenot J, Auger I, Toussirot E, Wendling D, Mattei JP, Nogueira L, Mugnier B, Legeron P, Landt O, Serre G, Roudier J, Roudier C.
    Arthritis Rheum; 2007 Dec 15; 57(8):1426-30. PubMed ID: 18050183
    [Abstract] [Full Text] [Related]

  • 19. Quantitative magnetic resonance imaging of the hands and wrists of children with juvenile rheumatoid arthritis.
    Graham TB, Laor T, Dardzinski BJ.
    J Rheumatol; 2005 Sep 15; 32(9):1811-20. PubMed ID: 16142882
    [Abstract] [Full Text] [Related]

  • 20. Etanercept in severe active rheumatoid arthritis: first Australian experience.
    Perera LC, Tymms KE, Wilson BJ, Shadbolt B, Brook AS, Dorai Raj AK, Khoo KB.
    Intern Med J; 2006 Oct 15; 36(10):625-31. PubMed ID: 16958637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.